Cargando…
Efficacy and safety of intrawound vancomycin in primary hip and knee arthroplasty: a systematic review and meta-analysis: implications for the design of a randomized controlled trial
AIMS: The efficacy and safety of intrawound vancomycin for preventing surgical site infection in primary hip and knee arthroplasty is uncertain. METHODS: A systematic review of the literature was conducted, indexed from inception to March 2020 in PubMed, Web of Science, Cochrane Library, Embase, and...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Editorial Society of Bone & Joint Surgery
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649508/ https://www.ncbi.nlm.nih.gov/pubmed/33135425 http://dx.doi.org/10.1302/2046-3758.911.BJR-2020-0190.R2 |
_version_ | 1783607343704965120 |
---|---|
author | Xu, Hong Yang, Jingli Xie, Jinwei Huang, Zeyu Huang, Qiang Cao, Guorui Pei, Fuxing |
author_facet | Xu, Hong Yang, Jingli Xie, Jinwei Huang, Zeyu Huang, Qiang Cao, Guorui Pei, Fuxing |
author_sort | Xu, Hong |
collection | PubMed |
description | AIMS: The efficacy and safety of intrawound vancomycin for preventing surgical site infection in primary hip and knee arthroplasty is uncertain. METHODS: A systematic review of the literature was conducted, indexed from inception to March 2020 in PubMed, Web of Science, Cochrane Library, Embase, and Google Scholar databases. All studies evaluating the efficacy and/or safety of intrawound vancomycin in patients who underwent primary hip and knee arthroplasty were included. Incidence of periprosthetic joint infection (PJI), superficial infection, aseptic wound complications, acute kidney injury, anaphylactic reaction, and ototoxicity were meta-analyzed. Results were reported as odds ratios (ORs) and 95% confidence intervals (CIs). The quality of included studies was assessed using the risk of bias in non-randomized studies of interventions (ROBINS-I) assessment tool. RESULTS: Nine studies involving 4,607 patients were included. Intrawound vancomycin was associated with lower incidence of PJI (30 patients (1.20%) vs 58 control patients (2.75%); OR 0.44, 95% CI 0.28 to 0.69) and simultaneous acute kidney injury (four patients (0.28%) vs four control patients (0.35%), OR 0.71, 95% CI 0.19 to 2.55). However, it did not reduce risk of superficial infection (four patients (0.67%) vs six control patients (1.60%), OR 0.60, 95% CI 0.17 to 2.12) and was associated with higher incidence of aseptic wound complications (23 patients (2.15%) vs eight in control patients (0.96%), OR 2.39, 95% CI 1.09 to 5.23). Four studies reported no anaphylactic reactions and three studies reported no ototoxicity in any patient group. CONCLUSION: The current literature suggests that intrawound vancomycin used in primary hip and knee arthroplasty may reduce incidence of PJI, but it may also increase risk of aseptic wound complications. Cite this article: Bone Joint Res 2020;9(11):778–788. |
format | Online Article Text |
id | pubmed-7649508 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The British Editorial Society of Bone & Joint Surgery |
record_format | MEDLINE/PubMed |
spelling | pubmed-76495082020-11-17 Efficacy and safety of intrawound vancomycin in primary hip and knee arthroplasty: a systematic review and meta-analysis: implications for the design of a randomized controlled trial Xu, Hong Yang, Jingli Xie, Jinwei Huang, Zeyu Huang, Qiang Cao, Guorui Pei, Fuxing Bone Joint Res Infection AIMS: The efficacy and safety of intrawound vancomycin for preventing surgical site infection in primary hip and knee arthroplasty is uncertain. METHODS: A systematic review of the literature was conducted, indexed from inception to March 2020 in PubMed, Web of Science, Cochrane Library, Embase, and Google Scholar databases. All studies evaluating the efficacy and/or safety of intrawound vancomycin in patients who underwent primary hip and knee arthroplasty were included. Incidence of periprosthetic joint infection (PJI), superficial infection, aseptic wound complications, acute kidney injury, anaphylactic reaction, and ototoxicity were meta-analyzed. Results were reported as odds ratios (ORs) and 95% confidence intervals (CIs). The quality of included studies was assessed using the risk of bias in non-randomized studies of interventions (ROBINS-I) assessment tool. RESULTS: Nine studies involving 4,607 patients were included. Intrawound vancomycin was associated with lower incidence of PJI (30 patients (1.20%) vs 58 control patients (2.75%); OR 0.44, 95% CI 0.28 to 0.69) and simultaneous acute kidney injury (four patients (0.28%) vs four control patients (0.35%), OR 0.71, 95% CI 0.19 to 2.55). However, it did not reduce risk of superficial infection (four patients (0.67%) vs six control patients (1.60%), OR 0.60, 95% CI 0.17 to 2.12) and was associated with higher incidence of aseptic wound complications (23 patients (2.15%) vs eight in control patients (0.96%), OR 2.39, 95% CI 1.09 to 5.23). Four studies reported no anaphylactic reactions and three studies reported no ototoxicity in any patient group. CONCLUSION: The current literature suggests that intrawound vancomycin used in primary hip and knee arthroplasty may reduce incidence of PJI, but it may also increase risk of aseptic wound complications. Cite this article: Bone Joint Res 2020;9(11):778–788. The British Editorial Society of Bone & Joint Surgery 2020-10-31 /pmc/articles/PMC7649508/ /pubmed/33135425 http://dx.doi.org/10.1302/2046-3758.911.BJR-2020-0190.R2 Text en © 2020 Author(s) et al. https://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND 4.0) licence, which permits the copying and redistribution of the work only, and provided the original author and source are credited. |
spellingShingle | Infection Xu, Hong Yang, Jingli Xie, Jinwei Huang, Zeyu Huang, Qiang Cao, Guorui Pei, Fuxing Efficacy and safety of intrawound vancomycin in primary hip and knee arthroplasty: a systematic review and meta-analysis: implications for the design of a randomized controlled trial |
title | Efficacy and safety of intrawound vancomycin in primary hip and knee arthroplasty: a systematic review and meta-analysis: implications for the design of a randomized controlled trial |
title_full | Efficacy and safety of intrawound vancomycin in primary hip and knee arthroplasty: a systematic review and meta-analysis: implications for the design of a randomized controlled trial |
title_fullStr | Efficacy and safety of intrawound vancomycin in primary hip and knee arthroplasty: a systematic review and meta-analysis: implications for the design of a randomized controlled trial |
title_full_unstemmed | Efficacy and safety of intrawound vancomycin in primary hip and knee arthroplasty: a systematic review and meta-analysis: implications for the design of a randomized controlled trial |
title_short | Efficacy and safety of intrawound vancomycin in primary hip and knee arthroplasty: a systematic review and meta-analysis: implications for the design of a randomized controlled trial |
title_sort | efficacy and safety of intrawound vancomycin in primary hip and knee arthroplasty: a systematic review and meta-analysis: implications for the design of a randomized controlled trial |
topic | Infection |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649508/ https://www.ncbi.nlm.nih.gov/pubmed/33135425 http://dx.doi.org/10.1302/2046-3758.911.BJR-2020-0190.R2 |
work_keys_str_mv | AT xuhong efficacyandsafetyofintrawoundvancomycininprimaryhipandkneearthroplastyasystematicreviewandmetaanalysisimplicationsforthedesignofarandomizedcontrolledtrial AT yangjingli efficacyandsafetyofintrawoundvancomycininprimaryhipandkneearthroplastyasystematicreviewandmetaanalysisimplicationsforthedesignofarandomizedcontrolledtrial AT xiejinwei efficacyandsafetyofintrawoundvancomycininprimaryhipandkneearthroplastyasystematicreviewandmetaanalysisimplicationsforthedesignofarandomizedcontrolledtrial AT huangzeyu efficacyandsafetyofintrawoundvancomycininprimaryhipandkneearthroplastyasystematicreviewandmetaanalysisimplicationsforthedesignofarandomizedcontrolledtrial AT huangqiang efficacyandsafetyofintrawoundvancomycininprimaryhipandkneearthroplastyasystematicreviewandmetaanalysisimplicationsforthedesignofarandomizedcontrolledtrial AT caoguorui efficacyandsafetyofintrawoundvancomycininprimaryhipandkneearthroplastyasystematicreviewandmetaanalysisimplicationsforthedesignofarandomizedcontrolledtrial AT peifuxing efficacyandsafetyofintrawoundvancomycininprimaryhipandkneearthroplastyasystematicreviewandmetaanalysisimplicationsforthedesignofarandomizedcontrolledtrial |